Health Care: Health Services

Navidea Biopharmaceuticals Inc (NAVB: AMEX)

$1.29 0.01 | 0.78%
08/27/14 - 01:46 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 1.13M 78.74K 597.73K 10.70M
Cost of Sales 332.82K 0.00 0.00 2.98M
Gross Operating Profit 797.82K 78.74K 597.73K 7.72M
Selling, General, and Administrative Expenses 15.53M 11.18M 9.55M 4.58M
Research & Development 23.71M 16.89M 15.15M 9.22M
Operating Income before D & A (EBITDA) -38.44M -27.99M -24.10M -6.09M
Depreciation & Amortization 1.17M 744.74K 180.35K 223.46K
Interest Income 18.84K 25.04K 25.76K 8.80K
Other Income - Net -1.50M -26.61K -955.59K -43.02M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -41.09M -28.74M -25.21M -49.32M
Interest Expense 2.78M 1.17M 13.33K 554.99K
Pre-Tax Income -43.87M -29.90M -25.23M -49.88M
Income Taxes 0.00 0.00 -7.88M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -42.70M -29.16M -17.17M -49.88M
Net Income From Discontinued Operations 0.00 0.00 22.78M -86.60K
Net Income From Total Operations -42.70M -29.16M 5.61M -49.96M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -42.70M -29.16M 5.61M -49.96M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-42.70M -29.16M -17.17M -49.88M
Preferred Dividends
Net Income Available To Common -42.70M -29.20M -17.27M -58.09M
Basic EPS from Continuing Ops. -0.35 -0.29 -0.17 -0.72
Basic EPS from Discontinued Ops. 0.00 0.00 0.23 0.00
Basic EPS from Total Operations -0.35 -0.29 0.06 -0.72
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.35 -0.29 0.06 -0.72
Basic Normalized Net Income/Share -0.35 -0.29 -0.17 -0.72
EPS fr Continuing Ops. -0.35 -0.29 -0.19 -0.72
EPS fr Discontinued Ops 0.00 0.00 0.23 0.00
EPS fr Total Ops. -0.35 -0.29 0.04 -0.72
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.02 0.00
EPS, Total -0.35 -0.29 0.06 -0.72
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.35 -0.29 -0.19 -0.72
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NAVB

Latest NAVB Headlines from TheStreet

More Financial News for NAVB

Press Releases for NAVB

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter